Anixa Biosciences
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	10/31/2021	10/31/2022	10/31/2023	10/31/2026	10/31/2027
Revenue % change YoY	$512.5K N/A	$2.46B 481656.09%	$210K -99.99%	Avg: $88.60K Low: $88.60K High: $88.60K avg. -57.80%	Avg: $34M Low: $34M High: $34M avg. 38274.28%
Net Income % change YoY	$-12.94M N/A	$-13.49M -4.20%	$-9.81M 27.27%	Avg: $-5.57M Low: $-5.57M High: $-5.57M avg. 43.16%	Avg: $31.28M Low: $31.28M High: $31.28M avg. 661.11%
EBITDA % change YoY	$-13.08M N/A	$-13.83M -5.74%	$-10.96M 20.73%	Avg: $-35.53K Low: $-35.53K High: $-35.53K avg. 99.67%	Avg: $-13.63M Low: $-13.63M High: $-13.63M avg. -38275.01%
EPS % change YoY	-$0.45 N/A	-$0.44 2.22%	-$0.32 27.27%	Avg: -$0.18 Low: -$0.18 High: -$0.18 avg. 43.75%	Avg: $1.01 Low: $1.01 High: $1.01 avg. 661.11%
Operating Expenses % change YoY	$13.26M N/A	$13.87M 4.61%	$11.06M -20.28%	Avg: $1.19M Low: $1.19M High: $1.19M avg. -89.19%	Avg: $458.41M Low: $458.41M High: $458.41M avg. 38274.29%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 352.13% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is -5.57M, average is -5.57M and high is -5.57M.

Wall Street analysts forecast annual average revenue growth of 19108.23% in 2026-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $88.60K, average is $88.60K and high is $88.60K.

Wall Street analysts forecast annual average earnings growth of 352.43% in 2026-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.18, average is -$0.18 and high is $-0.18.

In the last twelve months analysts have been covering Anixa Biosciences stock. The most successful analyst is Matthew Barcus.